Cardiologycoronary artery diseaseORBITA-2
Focal vs. Diffuse Coronary Artery Disease: How Disease Pattern Influences PCI’s Placebo-Controlled Symptom Relief in ORBITA-2
By MedXY|Apr 22, 2026
ORBITA-2 reveals PCI’s superior placebo-controlled angina relief in focal vs. diffuse coronary artery disease, with physiological disease patterns guiding treatment decisions.